# Geldanamycin Analogue in Treating Patients With Advanced Cancer

> **NCT00003969** · PHASE1 · COMPLETED · sponsor: **Cancer Research UK**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** tanespimycin

## Key facts

- **NCT ID:** NCT00003969
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-08
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003969, "Geldanamycin Analogue in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*